A Double-blind, Randomized, Multicenter, Active- and Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of CG100649 in Osteoarthritis Patients
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Polmacoxib (Primary) ; Celecoxib
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors CrystalGenomics
- 12 Jan 2016 Interim results published in CrystalGenomics media release.
- 09 Feb 2015 Based on the results of this trial, the South Korean Ministry of Food and Drug Safety (MFDS) has approved an NDA for polmacoxib (Acelex), according to a CrystalGenomics media release.
- 09 Feb 2015 Results published in CrystalGenomics media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History